This study aimed to assess the correlation between HCG levels after ovulation triggering and ICSI outcomes, affected by HCG formulation and dose
The aims of this study are: 1. To assess the correlation between serum human chorionic gonadotropin (hCG) level after ovulation triggering and intracytoplasmic sperm injection (ICSI) outcome including: oocyte maturity and quality, good quality embryo rate, blastocyst formation rate and pregnancy rate 2. To determine if there is an association between type and dose of the trigger and ICSI outcome.
Study Type
OBSERVATIONAL
Enrollment
100
Final oocyte maturation will be triggered by IM administration of 10000 IU of uHCG (Choriomon)
Final oocyte maturation will be triggered by SC administration of 6500 IU of rHCG (Ovitrelle)
Final oocyte maturation will be triggered by combined SC administration of 0.1 mg of GnRHa (Decapeptyl, Triptorelin) and IM administration of 2500 IU of uHCG (Choriomon)
Royal Center
Al Mansurah, Dakahlia Governorate, Egypt
Clinical pregnancy rate
Number of clinical pregnancies (defined as presence of at least one intrauterine gestational sac with fetal pole and cardiac activity on TVS scan at 4-6 weeks after the ET) divided by the number of ET procedures
Time frame: 6 weeks after embryo transfer
Oocyte maturation rate
Number of mature oocytes divided by the number of retrieved oocytes
Time frame: On 1 day of oocyte retrieval
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.